Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 75 of 329 entries
View as:

Nanochip Technology in Monitoring Treatment Response and Detecting Relapse in Participants With Diffuse Large B-Cell Lymphoma

Phase: N/A Priority: Normal
NCT ID: NCT03656835 Org: User:
Start: 09/26/18 End: 11/19/25 Due: 11/19/26

Lenalidomide and Pidilizumab in Treating Patients With Relapsed or Refractory Multiple Myeloma

Phase: N/A Priority: Normal
NCT ID: NCT02077959 Org: User:
Start: 03/03/14 End: 05/24/19 Due: 05/24/20

Quality of Life and Supportive Care Preferences Following Radiation Therapy in Prostate Cancer Survivors

Phase: N/A Priority: Normal
NCT ID: NCT02704377 Org: User:
Start: 05/08/16 End: 04/06/23 Due: 04/06/24

Mirvetuximab Soravtansine and Rucaparib Camsylate in Treating Participants With Recurrent Endometrial, Ovarian, Fallopian Tube or Primary Peritoneal Cancer

Phase: N/A Priority: Normal
NCT ID: NCT03552471 Org: User:
Start: 07/12/18 End: 12/19/22 Due: 12/19/23

Evaluating Modifiable Biomarkers for the Prediction of Immunotherapy Response and Toxicity

Phase: N/A Priority: Normal
NCT ID: NCT04954885 Org: User:
Start: 05/18/21 End: 10/12/22 Due: 10/12/23

Transoral Robotic Surgery in Treating Patients With Benign or Malignant Tumors of the Head and Neck

Phase: N/A Priority: Normal
NCT ID: NCT01473784 Org: User:
Start: 12/03/07 End: 09/10/25 Due: 09/10/26

Effects of Tobacco Cut and Nicotine Form on the Abuse Liability of Moist Snuff

Phase: N/A Priority: Normal
NCT ID: NCT06249984 Org: User:
Start: 12/20/24 End: 12/31/25 Due: 12/31/26

Low-Dose Radiotherapy For Patients With SARS-COV-2 (COVID-19) Pneumonia

Phase: N/A Priority: Normal
NCT ID: NCT04466683 Org: User:
Start: 08/28/20 End: 12/31/25 Due: 12/31/26

HPV Vaccine Intervention for Young Sexual Minority Men

Phase: N/A Priority: Normal
NCT ID: NCT04032106 Org: User:
Start: 10/03/19 End: 03/31/22 Due: 03/31/23

Fractional CO2 Laser Therapy for Survivors of Breast Malignancies

Phase: N/A Priority: Normal
NCT ID: NCT03307044 Org: User:
Start: 11/16/17 End: 05/05/22 Due: 05/05/23

Development of a Genetic Counseling Patient Preference Intervention for Women at Elevated Risk for Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT05158452 Org: User:
Start: 12/09/20 End: 10/30/22 Due: 10/30/23

Evaluating Anti-Tobacco Message Effectiveness Among Lesbian, Gay, Bisexual, and Transgender Young Adults

Phase: N/A Priority: Normal
NCT ID: NCT05393869 Org: User:
Start: 04/14/21 End: 11/14/22 Due: 11/14/23

Hyperthermic Intraperitoneal Chemotherapy With Cisplatin During Surgery or Cisplatin Before Surgery for the Treatment of Stage III or IV Ovarian, Fallopian Tube or Peritoneal Cancer

Phase: N/A Priority: Normal
NCT ID: NCT05415709 Org: User:
Start: 06/13/22 End: 12/31/26 Due: 12/31/27

Phase II NCT (Neoadjuvant Chemotherapy) w/ Weekly Abraxane in Combination With Carboplatin & Bevacizumab in Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00675259 Org: User:
Start: 07/31/08 End: 03/31/14 Due: 03/31/15

Stereotactic Body Radiation Therapy and Transarterial Chemoembolization in Treating Patients With Liver Cancer That Cannot Be Removed by Surgery

Phase: N/A Priority: Normal
NCT ID: NCT02507765 Org: User:
Start: 07/31/15 End: 01/05/21 Due: 01/05/22

Communication & Peer Support Effects on Physical Activity in Overweight Postmenopausal Women

Phase: N/A Priority: Normal
NCT ID: NCT01940016 Org: User:
Start: 04/01/07 End: 11/01/09 Due: 11/01/10

Correlation Between the Genetic and Neuroimaging Signatures in Newly Diagnosed Glioblastoma Patients Before Surgery

Phase: N/A Priority: Normal
NCT ID: NCT02590497 Org: User:
Start: 03/20/16 End: 10/26/17 Due: 10/26/18

Azacytidine and Bortezomib in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia or Myelodysplastic Syndromes

Phase: N/A Priority: Normal
NCT ID: NCT00624936 Org: User:
Start: 04/30/08 End: 06/30/14 Due: 06/30/15

Papaverine in Combination With Chemoradiation for the Treatment of Stage II-III Non-small Cell Lung Cancer

Phase: N/A Priority: Normal
NCT ID: NCT05136846 Org: User:
Start: 12/06/21 End: 12/31/26 Due: 12/31/27

Evaluation of Vaginal Microbiome as a Biomarker for the Improvement of Vaginal Health in Women With Breast Cancer, ARISE Study

Phase: N/A Priority: Normal
NCT ID: NCT05946668 Org: User:
Start: 06/06/23 End: 03/01/25 Due: 03/01/26

Nicotine and Tobacco Message Framing Among LGBT Young Adults

Phase: N/A Priority: Normal
NCT ID: NCT05972941 Org: User:
Start: 06/19/23 End: 02/06/24 Due: 02/06/25

Capecitabine, Carboplatin and Weekly Paclitaxel for Patients With Solid Tumors and Adenocarcinoma of Unknown Primary

Phase: N/A Priority: Normal
NCT ID: NCT00201734 Org: User:
Start: 06/30/05 End: 06/30/13 Due: 06/30/14

Pilot Study of a MIND Diet Intervention in Women Undergoing Active Treatment for Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT05984888 Org: User:
Start: 10/26/23 End: 06/30/25 Due: 06/30/26

Ondansetron Versus Palonosetron Antiemetic Regimen Prior to Highly Emetogenic Chemotherapy(HEC)

Phase: N/A Priority: Normal
NCT ID: NCT01640340 Org: User:
Start: 01/31/11 End: 08/31/11 Due: 08/31/12

Pyrazoloacridine in Treating Women With Refractory Metastatic Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00003041 Org: User:
Start: 07/31/97 End: 01/31/02 Due: 01/31/03